Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The prevalence of pulmonary hypertension in adults with sickle cell disease, the mechanism of its development, and its prospective prognostic significance are unknown. METHODS: We performed Doppler echocardiographic assessments of pulmonary-artery systolic pressure in 195 consecutive patients (82 men and 113 women; mean [+/-SD] age, 36+/-12 years). Pulmonary hypertension was prospectively defined as a tricuspid regurgitant jet velocity of at least 2.5 m per second. Patients were followed for a mean of 18 months, and data were censored at the time of death or loss to follow-up. RESULTS: Doppler-defined pulmonary hypertension occurred in 32 percent of patients. Multiple logistic-regression analysis, with the use of the dichotomous variable of a tricuspid regurgitant jet velocity of less than 2.5 m per second or 2.5 m per second or more, identified a self-reported history of cardiovascular or renal complications, increased systolic blood pressure, high lactate dehydrogenase levels (a marker of hemolysis), high levels of alkaline phosphatase, and low transferrin levels as significant independent correlates of pulmonary hypertension. The fetal hemoglobin level, white-cell count, and platelet count and the use of hydroxyurea therapy were unrelated to pulmonary hypertension. A tricuspid regurgitant jet velocity of at least 2.5 m per second, as compared with a velocity of less than 2.5 m per second, was strongly associated with an increased risk of death (rate ratio, 10.1; 95 percent confidence interval, 2.2 to 47.0; P<0.001) and remained so after adjustment for other possible risk factors in a proportional-hazards regression model. CONCLUSIONS: Pulmonary hypertension, diagnosed by Doppler echocardiography, is common in adults with sickle cell disease. It appears to be a complication of chronic hemolysis, is resistant to hydroxyurea therapy, and confers a high risk of death. Therapeutic trials targeting this population of patients are indicated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with higher rates of hemolysis have lower steady-state Hb levels and are more likely to develop vascular injury and organ dysfunction as they age, manifesting as pulmonary hypertension, diastolic left heart disease, and renal dysfunction (proteinuria, albuminuria, and chronic kidney dysfunction) (62, 64, 65, 70, 79).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [64]
Citations
Cites
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A., Devereux, R., Feigenbaum, H., Gutgesell, H., Reichek, N., Sahn, D., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,121
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Self-citationQuiñones, M. A., Otto, C. M., Stoddard, M., Waggoner, A., & Zoghbi, W. A. (2002) · Journal of the American Society of Echocardiography · doi:10.1067/mje.2002.120202 · Cited by 2,130
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Primary Pulmonary Hypertension
Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Self-citationCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Cited by
Items 501–600 of 999
The Burden of Pulmonary Hypertension in Resource-Limited Settings
Gidwani, S., & Nair, A. P. (2014) · Global Heart · doi:10.1016/j.gheart.2014.08.007 · Cited by 29
Overview of Sickle Cell Anemia Pathophysiology
Steinberg, M. H. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_3 · Cited by 31
Pulmonary hypertension among 5 to 18 year old children with sickle cell anaemia in Nigeria
Sokunbi, O. J., Ekure, E. N., Temiye, E. O., Anyanwu, R., & Okoromah, C. A. N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184287 · Cited by 30
Sickle cell disease as a vascular disorder
Ofori-Acquah, S. F. (2020) · Expert Review of Hematology · doi:10.1080/17474086.2020.1758555 · Cited by 30
A phenotypic risk score for predicting mortality in sickle cell disease
Sachdev, V., Tian, X., Gu, Y., Nichols, J., Sidenko, S., Li, W., Beri, A., Layne, W. A., Allen, D. T., Wu, C. O., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17342 · Cited by 35
Self-citationBadaki‐Makun, O., Scott, J. P., Panepinto, J. A., Casper, T. C., Hillery, C. A., Dean, J. M., & Brousseau, D. C. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.24925 · Cited by 28
The proteome of sickle cell disease: insights from exploratory proteomic profiling
Yuditskaya, S., Suffredini, A. F., & Kato, G. J. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.88 · Cited by 28
Pulmonary Complications of Sickle Cell Disease
Khoury, R. A., Musallam, K. M., Mroueh, S. M., & Abboud, M. R. (2011) · Hemoglobin · doi:10.3109/03630269.2011.621149 · Cited by 30
Pohlen, M., Gerth, H. U., Liersch, R., Koschmieder, S., Mesters, R. M., Keßler, T., Appelmann, I., Müller‐Tidow, C., & Berdel, W. E. (2011) · American Journal of Hematology · doi:10.1002/ajh.22165 · Cited by 28
Riociguat use in sickle cell related chronic thromboembolic pulmonary hypertension: A case series
Weir, N. A., Conrey, A. K., Lewis, D., & Mehari, A. (2018) · Pulmonary Circulation · doi:10.1177/2045894018791802 · Cited by 27
Adenosine deaminase–adenosine pathway in hemolysis-associated pulmonary hypertension
Tofovic, S. P., Jackson, E. K., & Rafikova, O. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.12.043 · Cited by 27
Sickle cell microvascular paradox—oxygen supply‐demand mismatch
Detterich, J. A., Kato, R. M., Bush, A., Chalacheva, P., Ponce, D., Zoysa, M. Y. D., Shah, P., Khoo, M. C. K., Meiselman, H. J., Coates, T. D., et al. (2019) · American Journal of Hematology · doi:10.1002/ajh.25476 · Cited by 27
Forrest, S. J., Kim, A., Carbonella, J., & Pashankar, F. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23338 · Cited by 27
Flavanols and Cardiovascular Health: Effects on the circulating NO Pool in Humans
Balzer, J., Heiß, C., Schroeter, H., Brouzos, P., Kleinbongard, P., Matern, S., Lauer, T., Rassaf, T., & Kelm, M. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200606001-00006 · Cited by 28
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
Rahimi, Z., & Parsian, A. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.024 · Cited by 29
Kato, G. J. (2008) · Hematology · doi:10.1182/asheducation-2008.1.186 · Cited by 30
Chaturvedi, S., Ghafuri, D. L., Kassim, A. A., Rodeghier, M., & DeBaun, M. R. (2017) · American Journal of Hematology · doi:10.1002/ajh.24598 · Cited by 26
Diastolic dysfunction is associated with exercise impairment in patients with sickle cell anemia
Alsaied, T., Niss, O., Powell, A. W., Fleck, R. J., Cnota, J. F., Chin, C. C., Malik, P., Quinn, C. T., & Taylor, M. D. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27113 · Cited by 27
Vasculopathy in Sickle Cell Disease: From Red Blood Cell Sickling to Vascular Dysfunction
Nader, É., Conran, N., Romana, M., & Connes, P. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200024 · Cited by 38
Global burden of transfusion in sickle cell disease
Inusa, B. P. D., Atoyebi, W., Andemariam, B., Hourani, J., & Omert, L. (2023) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2023.103764 · Cited by 30
Pulmonary hypertension in chronic hemolytic anemias: Pathophysiology and treatment
Haw, A., & Palevsky, H. I. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.02.020 · Cited by 28
Alsaied, T., Niss, O., Tretter, J. T., Powell, A. W., Chin, C. C., Fleck, R. J., Cnota, J. F., Malik, P., Quinn, C. T., Nagueh, S. F., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58662-8 · Cited by 29
Chronic organ injuries in children with sickle cell disease
Allali, S., Taylor, M., Brice, J., & de Montalembert, M. (2021) · Haematologica · doi:10.3324/haematol.2020.271353 · Cited by 31
Allogeneic cellular and autologous stem cell therapy for sickle cell disease: ‘whom, when and how’
Freed, J., Talano, J., Small, T. N., Ricci, A. M., & Cairo, M. S. (2011) · Bone Marrow Transplantation · doi:10.1038/bmt.2011.245 · Cited by 26
Dosunmu, A. O., Balogun, T. M., Adeyeye, O. O., Daniel, F. A., Akinola, R., Josephine, J., Akinbami, A., Sagoe, A., & Onadeko, B. O. (2014) · Nigerian Medical Journal · doi:10.4103/0300-1652.129661 · Cited by 25
Tam, D. H., & Farber, H. W. (2006) · American Journal of Hematology · doi:10.1002/ajh.20603 · Cited by 25
Sable, C., Aliyu, Z. Y., Dham, N., Nouraie, M. S., Sachdev, V., Sidenko, S., Miasnikova, G., Polyakova, L. A., Sergueeva, A., Okhotin, D. J., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.051839 · Cited by 32
Self-citationAtichartakarn, V., Chuncharunee, S., Archararit, N., Udomsubpayakul, U., Lee, R., Tunhasiriwet, A., & Aryurachai, K. (2013) · European Journal Of Haematology · doi:10.1111/ejh.12242 · Cited by 25
Association of circulating transcriptomic profiles with mortality in sickle cell disease
Desai, A. A., Lei, Z., Bahroos, N., Maienschein‐Cline, M., Saraf, S. L., Zhang, X., Shah, B. N., Nouraie, M. S., Abbasi, T. A., Patel, A. R., et al. (2017) · Blood · doi:10.1182/blood-2016-11-752279 · Cited by 26
Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana
Antwi‐Boasiako, C., & Campbell, A. (2018) · Vascular Health and Risk Management · doi:10.2147/vhrm.s163228 · Cited by 30
Fitzgerald, M., Fagan, K., Herbert, D. E., Al-Ali, M., Mugal, M., & Haynes, J. (2012) · Southern Medical Journal · doi:10.1097/smj.0b013e318256b55b · Cited by 25
Expression of CD1d and presence of invariant NKT cells in classical Hodgkin lymphoma
Xu, C., de Vries, R., Visser, L., Diepstra, A., Gadola, S. D., Poppema, S., & van den Berg, A. (2010) · American Journal of Hematology · doi:10.1002/ajh.21743 · Cited by 27
Dahoui, H. A., Hayek, M. N., Nietert, P. J., Arabi, M. T., Muwakkit, S. A., Saab, R. H., Bissar, A. N., Jumaa, N. M., Farhat, F. S., Dabbous, I., et al. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22306 · Cited by 27
Echocardiographic findings in patients with sickle cell disease
Naoman, S. G., Nouraie, M. S., Castro, O. L., Nwokolo, C., Fadojutimi-Akinsiku, M., Diaz, S. F., Willie-Carnegie, G., Andrews, N., & Gordeuk, V. R. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0764-0 · Cited by 25
Self-citationAssociation of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension
Landburg, P. P., Teerlink, T., van Beers, E. J., Muskiet, F. A. J., Kappers‐Klunne, M. C., van Esser, J. W. J., Gillavry, M. R. M., Biemond, B. J., Brandjes, D. P. M., Duits, A. J., et al. (2008) · Haematologica · doi:10.3324/haematol.12928 · Cited by 25
Rogers, N. M., Yao, M., Sembrat, J., George, M. P., Knupp, H. E., Ross, M., Sharifi‐Sanjani, M., Milošević, J., Croix, C. M. S., Rajkumar, R., et al. (2013) · Pulmonary Circulation · doi:10.1086/674754 · Cited by 26
Self-citationMokhtar, G. M., Adly, A. A. M., Elalfy, M. S., Tawfik, L. M., & Khairy, A. T. (2010) · Hemoglobin · doi:10.3109/03630260903554621 · Cited by 26
Chacko, P., Kraut, E. H., Zweier, J. L., Hitchcock, C. L., & Raman, S. V. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9426-z · Cited by 25
Endothelin-1 Predicts Hemodynamically Assessed Pulmonary Arterial Hypertension in HIV Infection
Parikh, R. V., Ma, Y., Scherzer, R., Heringer, A. S., MacGregor, J. S., Martin, J. N., Deeks, S. G., Ganz, P., & Hsue, P. Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146355 · Cited by 24
Management of Sickle Cell Disease in Children
Noronha, S. A., Sadreameli, S. C., & Strouse, J. J. (2016) · Southern Medical Journal · doi:10.14423/smj.0000000000000523 · Cited by 23
Delville, M., Manceau, S., Abdallah, N. A., Stolba, J., Awad, S., Damy, T., Gellen, B., Sabbah, L., Debbache, K., Audard, V., et al. (2016) · American Journal of Hematology · doi:10.1002/ajh.24600 · Cited by 24
Larissi, K., Politou, M., Margeli, A. P., Poziopoulos, C., Flevari, P., Terpos, E., Papassotiriou, I., & Voskaridou, E. (2019) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2019.04.011 · Cited by 25
The Role of Fibrocytes in Sickle Cell Lung Disease
Field, J. J., Burdick, M. D., DeBaun, M. R., Strieter, B. A., Liu, L., Mehrad, B., Rose, C. E., Linden, J., & Strieter, R. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033702 · Cited by 23
Ferroptosis as an emerging target in sickle cell disease
Fortuna, V., Lima, J. C., Oliveira, G. F., de Oliveira, Y. S. C., Getachew, B., Nekhai, S. A., Aschner, M., & Tizabi, Y. (2024) · Current Research in Toxicology · doi:10.1016/j.crtox.2024.100181 · Cited by 26
Revisiting the hyperhemolysis paradigm
Gladwin, M. T. (2015) · Blood · doi:10.1182/blood-2015-06-649491 · Cited by 26
Self-citationTantawy, A. A. G., Adly, A. A. M., Ismail, E. A. R., & Aly, S. H. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25234 · Cited by 27
Fitzhugh, C. D., & Walters, M. C. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017007708 · Cited by 24
Complications in the adult asplenic patient: A review for the emergency clinician
Long, B., Koyfman, A., & Gottlieb, M. A. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.03.049 · Cited by 23
Telen, M. J. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001469 · Cited by 23
Leukocytosis is a risk factor for lung function deterioration in children with sickle cell disease
Tassel, C., Arnaud, C., Kulpa, M., Fleurence, E., Kandem, A., Madhi, F., Bernaudin, F., & Delacourt, C. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2010.12.024 · Cited by 26
What's New in the Pathophysiology of Sickle Cell Disease?
Adekile, A. D. (2013) · Medical Principles and Practice · doi:10.1159/000350283 · Cited by 23
Rigano, P., Pecoraro, A., Calvaruso, G., Steinberg, M. H., Iannello, S., & Maggio, A. (2013) · American Journal of Hematology · doi:10.1002/ajh.23531 · Cited by 23
Prevalence of pulmonary hypertension in hereditary spherocytosis
Crary, S. E., Ramaciotti, C., & Buchanan, G. R. (2011) · American Journal of Hematology · doi:10.1002/ajh.22182 · Cited by 23
Knight‐Perry, J. E., Fuentes, L. D. L., Waggoner, A. D., Hoffmann, R. G., Blinder, M. A., Dávila‐Román, V. G., & Field, J. J. (2011) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2011.07.009 · Cited by 24
Defining the Phenotypes of Sickle Cell Disease
Ballas, S. K. (2011) · Hemoglobin · doi:10.3109/03630269.2011.610477 · Cited by 24
The Impact of Sickle Cell Disease on Exercise Capacity in Children
Chaudry, R. A., Bush, A., Rosenthal, M., & Crowley, S. (2013) · CHEST Journal · doi:10.1378/chest.12-0611 · Cited by 23
Pulmonary hypertension in β thalassaemia
Anthi, A., Orfanos, S. E., & Armaganidis, A. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70078-x · Cited by 23
Antisickling and toxicological evaluation of the leaves of Scoparia dulcis Linn (Scrophulariaceae)
Abere, T. A., Okoye, C. J., Agoreyo, F. O., Eze, G. I., Jesuorobo, R. I., Egharevba, C. O., & Aimator, P. O. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0928-5 · Cited by 26
Hebson, C. L., New, T. N., Record, E., Oster, M. E., Ehrlich, A. C., Border, W. L., James-Herry, A. G., & Kanaan, U. B. (2014) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000000184 · Cited by 23
Pittman, C., Hsieh, M. M., Coles, W. A., Tisdale, J. F., Weir, N. A., & Fitzhugh, C. D. (2017) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.335 · Cited by 22
Self-citationMöckesch, B., Charlot, K., Jumet, S., Romana, M., Divialle‐Doumdo, L., Hardy‐Dessources, M., Petras, M., Tressières, B., Tarer, V., Hüe, O., et al. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.02.001 · Cited by 24
Haymann, J., Hammoudi, N., Stankovic, K., Galactéros, F., Habibi, A., Avellino, V., Bartolucci, P., Benzerara, Y., Arlet, J., Djebbar, M., et al. (2017) · British Journal of Haematology · doi:10.1111/bjh.14969 · Cited by 23
Weatherald, J. C., Savale, L., & Humbert, M. J. C. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0783-5 · Cited by 24
Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia
Bernaudin, F., Pondarré, C., Galambrun, C., & Thuret, I. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-7299-9_4 · Cited by 29
Clinical trials in sickle cell disease: Adopting the combination chemotherapy paradigm
Steinberg, M. H. (2007) · American Journal of Hematology · doi:10.1002/ajh.21033 · Cited by 26
Therapeutics Targeting of Dysregulated Redox Equilibrium and Endothelial Dysfunction
Risbano, M. G., & Gladwin, M. T. (2013) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-45805-1_13 · Cited by 32
Self-citationKularatne, M., Gerges, C., Jevnikar, M., Humbert, M. J. C., & Montani, D. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11030078 · Cited by 35
Advances in Sickle Cell Therapies in the Hydroxyurea Era
Field, J. J., & Nathan, D. G. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00187 · Cited by 27
How I treat hypoxia in adults with hemoglobinopathies and hemolytic disorders
Machogu, E. M., & Machado, R. F. (2018) · Blood · doi:10.1182/blood-2018-03-818195 · Cited by 26
Nader, É., Garnier, Y., Connes, P., & Romana, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.728693 · Cited by 25
Sheikh, A. B., Nasrullah, A., Lopez, E. D., Din, M. T. U., Sagheer, S., Shah, I., Javed, N., & Shekhar, R. (2021) · Pulse · doi:10.1159/000519101 · Cited by 24
The Cardiopulmonary Complications of Sickle Cell Disease
Desai, A. A., Machado, R. F., & Cohen, R. T. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.07.014 · Cited by 25
Pulmonary Hypertension in a Case of Hb-Mainz Hemolytic Anemia
Lode, H. N., Krings, G. J., Schulze‐Neick, I., Dähmlow, S., Schroeder, U., Bonnet, R., DaPalma, J., Luck, W., Strauβ, G., Berger, F. F., et al. (2007) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e318032568c · Cited by 22
Predictors of osteoclast activity in patients with sickle cell disease
Nouraie, M. S., Cheng, K., Niu, X., Moore-King, E., Fadojutimi-Akinsi, M. F., Minniti, C. P., Sable, C., RANA, S. R., Dham, N., Campbell, A., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.042499 · Cited by 28
Self-citationBenza, R. L. (2008) · Lung · doi:10.1007/s00408-008-9092-8 · Cited by 23
Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension
Anthi, A., Tsangaris, I., Hamodraka, E. S., Lekakis, J. P., Armaganidis, A., & Orfanos, S. E. (2012) · Blood · doi:10.1182/blood-2012-04-422568 · Cited by 22
van Beers, E. J., van Eck‐Smit, B. L. F., Gillavry, M. R. M., Tuijn, C. F. J. V., van Esser, J. W. J., Brandjes, D. P. M., Kappers‐Klunne, M. C., Duits, A. J., Biemond, B. J., & Schnog, J. B. (2008) · CHEST Journal · doi:10.1378/chest.07-1694 · Cited by 22
AN OVERVIEW ON SICKLE CELL DISEASE PROFILE
Kaur, M., Dangi, C. B. S., & Singh, M. (2013) · Cited by 22
Sachdev, V., Hsieh, M. M., Jeffries, N. O., Noreuil, A., Li, W., Sidenko, S., Hannoush, H., Limerick, E. M., Wilson, D., Tisdale, J. F., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000387 · Cited by 23
Self-citationAllogeneic Hematopoietic Stem Cell Transplantation for Adults with Sickle Cell Disease
Saraf, S. L., & Rondelli, D. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101565 · Cited by 29
FRIEDMAN, D. M., Dozor, A. J., Milner, J., D’Souza, M., Talano, J., Moore, T. B., Shenoy, S. S., Shi, Q., Walters, M. C., Vichinsky, E. P., et al. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01298-7 · Cited by 23
Mechanisms and Clinical Complications of Hemolysis in Sickle Cell Disease and Thalassemia
Kato, G. J., & Gladwin, M. T. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.016 · Cited by 27
Self-citationNon-congenital heart disease associated pediatric pulmonary arterial hypertension
Ivy, D. D., Feinstein, J. A., Humpl, T., & Rosenzweig, E. B. (2009) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2009.09.004 · Cited by 25
Hipertensão arterial pulmonar associada à anemia falciforme
Machado, R. F. (2007) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132007000500015 · Cited by 30
Liem, R. I., Young, L., Lay, A. S., Pelligra, S. A., Labotka, R., & Thompson, A. A. (2010) · American Journal of Hematology · doi:10.1002/ajh.21793 · Cited by 23
Caughey, M. C., Hinderliter, A. L., Jones, S. K., Shah, S. P., & Ataga, K. I. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.11.067 · Cited by 21
A Critical Appraisal of the Updated 2014 Nice Pulmonary Hypertension Classification System
Lau, E., & Humbert, M. J. C. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.09.033 · Cited by 21
Lung Function Abnormalities in Sickle Cell Anaemia
Dei‐Adomakoh, Y., Afriyie-Mensah, J. S., Forson, A. G., Adadey, M., Ndanu, T. A., & Acquaye, J. K. (2019) · Advances in Hematology · doi:10.1155/2019/1783240 · Cited by 22
Physiological Evaluation for Endurance Exercise Prescription in Sickle Cell Disease
Messonnier, L. A., Gellen, B., Lacroix, R., Peyrot, S., Rupp, T., MIRA, J., Peyrard, A., Berkenou, J., Galactéros, F., Bartolucci, P., et al. (2019) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001993 · Cited by 22
Tubular Acidification Defect in Adults with Sickle Cell Disease
Cazenave, M., Audard, V., Bertocchio, J., Habibi, A., Baron, S., Prot‐Bertoye, C., Berkenou, J., Maruani, G., Stehlé, T., Cornière, N., et al. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07830719 · Cited by 23
Cardiovascular Function and Dysfunction in Sickle Cell Anemia
Haywood, L. J. (2009) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30807-5 · Cited by 21
Cardiac involvement in sickle β-thalassemia
Aessopos, A., Farmakis, D. T., Trompoukis, C., Tsironi, M., Moyssakis, I. E., Tsaftarides, P., & Karagiorga, M. (2008) · Annals of Hematology · doi:10.1007/s00277-008-0661-y · Cited by 23
Viswabandya, A., Baidya, S., Nair, S. C., Lakshmi, K. M., Mathews, V., George, B., Chandy, M., & Srivastava, A. (2010) · American Journal of Hematology · doi:10.1002/ajh.21741 · Cited by 21
High Prevalence of Pulmonary Hypertension in Homozygous Sickle Cell Patients with Leg Ulceration
Serarslan, G., Akgül, F., & Babayiğit, C. (2009) · Clinical and Experimental Hypertension · doi:10.1080/10641960802404078 · Cited by 21
Pulmonary hypertension in hemolytic anemias
Wahl, S. K., & Vichinsky, E. P. (2010) · F1000 Medicine Reports · doi:10.3410/m2-10 · Cited by 20
Pulmonary Hypertension in Sickle-Cell Disease: Comorbidities and Echocardiographic Findings
Akgül, F., Yalçın, F., Seyfeli, E., Uçar, E., Karazincir, S., Balcı, A., & Gali, E. (2007) · Acta Haematologica · doi:10.1159/000102588 · Cited by 22
Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
Papizan, J. B., Porter, S. N., Sharma, A., & Pruett‐Miller, S. M. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20200096 · Cited by 25
Infrared imaging of nitric oxide-mediated blood flow in human sickle cell disease
Gorbach, A. M., Ackerman, H. C., Liu, W., Meyer, J., Littel, P. L., Seamon, C. A., Footman, E., Chi, A., Zorca, S. M., Krajewski, M. L., et al. (2012) · Microvascular Research · doi:10.1016/j.mvr.2012.06.011 · Cited by 20
Endothelin receptor antagonists in sickle cell disease: A promising new therapeutic approach
Fox, B. M., & Kasztan, M. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.04.001 · Cited by 22
Differences of microparticle patterns between sickle cell anemia and hemoglobin SC patients
Garnier, Y., Ferdinand, S., Etienne‐Julan, M., Elana, G., Petras, M., Divialle‐Doumdo, L., Tressières, B., Lalanne‐Mistrih, M., Hardy‐Dessources, M., Connes, P., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177397 · Cited by 23
Metadata
- Authors
- Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., Hunter, L. A., Blackwelder, W. C., Schechter, A. N., Rodgers, G. P., Castro, O., & Ognibene, F. P.
- Affiliations
- National Institutes of Health (US)
- National Heart, Lung, and Blood Institute (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-02-26
- Volume
- 350
- Issue
- 9
- Pages
- 886-895
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2148547093
- Cited by
- 1,325
- References
- 42
- Citations by year
- 2026: 42 · 2025: 30 · 2024: 45 · 2023: 44 · 2022: 42 · 2021: 47 · 2020: 34 · 2019: 61 · 2018: 43 · 2017: 57 · 2016: 74 · 2015: 64 · 2014: 76 · 2013: 64 · 2012: 68
- FWCI
- 35.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Digital Howard (Howard University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- pulmonary hypertension, sickle cell disease, mortality risk, tricuspid regurgitation velocity, Doppler echocardiography, chronic hemolysis, hydroxyurea therapy, risk factors, alkaline phosphatase, lactate dehydrogenase, transferrin, cardiovascular complications, renal complications
- MeSH terms
- Adult, Anemia, Sickle Cell, Antisickling Agents, Blood Pressure, Cause of Death, Drug Resistance, Female, Hemolysis, Humans, Hydroxyurea, Hypertension, Pulmonary, Male, Pulmonary Artery, Risk Factors, Tricuspid Valve Insufficiency, Echocardiography, Doppler, Prevalence, Survival Rate, Logistic Models, Ventricular Function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.